Viral protein is an effective preventative against infectionMarch 23, 2007For parents, 8 million cases of acute middle ear infections every year add up to a lot of sleepless nights and trips to the pediatrician. But new research from a collaboration between Rockefeller University and St. Jude Children's Hospital could change all that. In the March 23 issue of PLoS Pathogens, Rockefeller's Vincent A. Fischetti and colleagues at St. Jude show that middle ear infections in mice can be prevented by giving the mice a lysin - a protein derived from a virus that infects bacteria. The new technology may prevent children with the flu from developing secondary ear infections and would be an attractive alternative to traditional antibiotics, to which bacteria are rapidly becoming resistant. The bacteria that cause middle ear infections, Streptococcus pneumoniae, aren't transmitted at school. They already reside on the mucosal membranes in the nose, waiting for their chance to strike. When a child catches the flu, or another virus that causes an upper respiratory infection, the bacteria seize the opportunity and migrate to the middle ear, causing a secondary infection. The new treatment would kill the bacteria before it had a chance to move.
"These bacteria take advantage of a viral infection by striking when our resistance is lowered," says Fischetti, head of Rockefeller's Laboratory of Bacterial Pathogenesis and Immunology. "You should start taking an antibiotic the moment you come down with the viral infection to prevent the secondary infection, but physicians are reluctant to do this for fear of increasing resistance to antibiotics. So we're really in a catch-22 situation." Fischetti's lab has done extensive research on lysins, which are proteins derived from viruses that normally infect bacteria. After a virus has infected the bacteria and replicated, it uses lysins to punch holes in the bacteria's cell wall, killing the bacteria, in order to escape. Fischetti's lab has studied many different lysins and found that they work even from outside the bacterial cell as well as from the inside. In addition, unlike antibiotics, which kill many of the body's beneficial bacteria along with the disease-causing ones they target, lysins are highly specific. Each lysin will only kill a specific type of bacteria, leaving the body's normal flora untouched. "We knew from our previous experiments that if you treat an animal infected or colonized with pneumococci or streptococci with these lysins, you could cure or decolonize them," says Fischetti. "But I was looking for a way to see if lysins would work for secondary infections too, and John McCullers had a very nice model system." The two researchers collaborated - Fischetti sent McCullers, a physician at St. Jude Children's Hospital Department of Infectious Diseases, the lysin, and McCullers tested his mice. He colonized his mice with S. pneumoniae, treated some of them with the lysin and then gave them all influenza. Eighty percent of the mice that did not receive the lysin came down with middle ear infections, but none of the mice given the lysin did. The treatment was 100 percent effective. "It is really a no-brainer experiment," says Fischetti. "If the bacteria aren't there, they cannot cause the secondary infection." "Secondary bacterial infections cause much of the sickness and about 25 percent of all deaths during flu season," says McCullers. "Eliminating these secondary infections could dramatically reduce sickness and death rates." Rockefeller University Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Particle Accelerator Binge Drinking Acid Rain Endoscopy Food Poisoning Chronic inflammation Self-esteem Herpes Thyroid Cancer Radiation Exposure HPV vaccine Eczema Bone Loss Wine Melanoma Ozone Hole Neanderthal Carbon Dioxide Biology Colonoscopy Leukemia Anxiety Chocolate Bipolar Omega-3 Fatty Acids
See More: Science News Tags | |||||||||||||||||||||
|
Related Infection Current Events and Infection News Articles Blood stem cell growth factor reverses memory decline in mice A human growth factor that stimulates blood stem cells to proliferate in the bone marrow reverses memory impairment in mice genetically altered to develop Alzheimer's disease, researchers at the University of South Florida and James A. Haley Hospital found. Researchers testing virus-gene therapy combination against melanoma Researchers at the Moores UCSD Cancer Center are injecting a modified herpes virus into melanoma tumors, hoping to kill the cancer cells while also bolstering the body's immune defenses against the disease. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. Measurements fail to identify TB patients who could benefit from shorter treatment course Tuberculosis (TB) is a difficult infection to treat and requires six months of multiple antibiotics to cure it. To combat the TB pandemic, a shorter and simpler drug treatment would be a huge advance since most TB occurs in resource-limited settings with poor public health infrastructures. New lab-on-a-chip measures mechanics of bacteria colonies Researchers at the University of Michigan have devised a microscale tool to help them understand the mechanical behavior of biofilms, slimy colonies of bacteria involved in most human infectious diseases. Clue to normal-tension glaucoma; herpes infection and corneal transplants The July issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes two studies that may influence clinical treatment of serious eye conditions. Joint replacement patients with diabetes greatly benefit from controlled glucose Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions. Scripps research scientists find key culprits in lupus The more than 1.5 million Americans with systemic lupus erythematosus (or lupus) suffer from a variety of symptoms that flare and subside, often including painful or swollen joints, extreme fatigue, skin rashes, fever, and kidney problems. Ultrasensitive detector promises improved treatment of viral respiratory infections A Vanderbilt chemist and a biomedical engineer have teamed up to develop a respiratory virus detector that is sensitive enough to detect an infection at an early stage, takes only a few minutes to return a result and is simple enough to be performed in a pediatrician's office. Plant protein 'doorkeepers' block invading microbes, study finds A group of plant proteins that "shut the door" on bacteria that would otherwise infect the plant's leaves has been identified for the first time by a team of researchers in Denmark, at the University of California, Davis, and at UC Berkeley. More Infection Current Events and Infection News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||